Annovis BioAdvance News Portfolio News

Annovis Bio Announces Third Quarter 2022 Results and Provides Corporate Update

By WebmasterNovember 8, 2022November 1st, 2024No Comments

Annovis Bio Announces Third Quarter 2022 Results and Provides Corporate Update

Previous PostBioAdvance Breaks Life Sciences Investing Record Year in 2022
Next PostImmunome Presents Preclinical Data on Novel Anti-EPN1 Antibody IMM20059 at the Society for Immunotherapy of Cancer’s (SITC) 37th Annual Meeting